Publication | Closed Access

The efficacy and safety of nab paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable pancreatic cancer compared with younger patients

OncologyPancreatic CancerElderly PatientsGastrointestinal OncologyYounger PatientsPharmacotherapyNab PaclitaxelMedicineRadiation Oncology